Tablet composition with solubilizing and slow release effects
A technology of composition and solubilizer, which is applied in the field of medicine, can solve problems such as adverse reactions of blood pressure elevation, and achieve the effects of convenient preparation, convenient control, and simple process flow
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0071] 1000 mirabegron sustained-release tablets, each containing 25mg mirabegron.
[0072] Mirabegron 25g,
[0073] Hypromellose 250g,
[0074] PEG300 50g,
[0075] Butylated Hydroxyanisole 10g
[0076] Magnesium stearate 2g~20g
[0077] Adhesive 25 ~ 150ml.
[0078] Preparation method: Mix mirabegron with skeleton material hypromellose, corrosion filler: PEG300, butylated hydroxyanisole, etc. according to the above weight parts, and use 2.5% ethyl cellulose for every 500g Su 95% ethanol solution 80ml. The powder mixed evenly above is made into a soft material, granulated through a 20 mesh sieve, ventilated and dried at 55-60°C, and the water content is controlled to be less than 3%. After granulation with a 14 mesh sieve, add the prescription The amount of magnesium stearate 5g, mixing, tabletting.
Embodiment 2
[0080] 1000 mirabegron sustained-release tablets, each containing 25mg mirabegron.
[0081] Mirabegron 25g,
[0082] Hypromellose 300g,
[0083] PEG300-Lactose 120g,
[0084] Butylated Hydroxyanisole 20g
[0086] Adhesive 25 ~ 150ml.
[0087] Preparation method: Mix mirabegron with skeleton material hypromellose, erodible filler (1:1 mixture of PEG300 and lactose by weight), butylated hydroxyanisole, etc. by equal volume addition method, and use 60ml95 % ethanol solution to make ethyl cellulose into a 2.5% solution, make the above mixed powder into a soft material, pass through a 26-mesh sieve to granulate, and ventilate and dry at 55-60°C to control the water content <3%. After the 14-mesh sieve is sized, the magnesium stearate of the prescribed amount is added, mixed evenly, compressed into tablets, and the tablet hardness is controlled between 7.5kg.
Embodiment 3
[0089] 1000 mirabegron sustained-release tablets, each containing 25mg mirabegron.
[0090] Mirabegron 25g,
[0091] Hypromellose 500g,
[0092] PEG300-Lactose 10g,
[0093] Butylated Hydroxyanisole 35g
[0094] Magnesium stearate 2g~20g
[0095] Adhesive 25 ~ 150ml.
[0096] Among them, the erodible filler (a mixture of PEG300 and lactose by weight 3:1).
PUM
Property | Measurement | Unit |
---|---|---|
Hardness | aaaaa | aaaaa |
Hardness | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com